CodeBreaK 101 di ASCO 2025: Sotorasib Triplet di KRAS CRC – Oncodaily
CodeBreaK 101 di ASCO 2025: Terapi Triple Sotorasib untuk Kanker Kolorektal KRAS (Oncodaily)
Isi lengkap artikel
ASCO 2025: CodeBreaK 101 shows sotorasib triplet therapy offers durable responses in KRAS G12C-mutant metastatic colorectal cancer. , ASCO 2025 Annual Meeting, CodeBreaK 101 trial, colorectal cancer, KRASG12C
Produk Terkait Artikel Ini
Produk ini dicocokkan otomatis berdasarkan judul, ringkasan, dan isi artikel.
Pertanyaan Umum
Which products are related to this article?
The system matched these relevant products from the article content: Lucius Sotorasib – Beli online SOTOLDX Sotorasib 120mg.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.